Reuters logo
BRIEF-Mycenax Biotech applies for clinic trial of biosimilar LusiNEX
November 6, 2017 / 5:56 AM / 19 days ago

BRIEF-Mycenax Biotech applies for clinic trial of biosimilar LusiNEX

Nov 6 (Reuters) - Mycenax Biotech Inc :

* Says it applied for the first phase of clinic trial for biosimilar LusiNEX, to MHRA(Medicines & Healthcare products Regulatory Agency)

Source text in Chinese: goo.gl/Gtfvh5

Further company coverage: (Beijing Headline News)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below